The activation of TLR9 is notable for the fact that SARS-CoV-2 itself has not been shown to activate TLR9 but adenoviruses do, suggesting that some severe COVID-19 patients may be co-infected with adeno- or other viruses in addition to SARS-CoV-2. This evidence concerns the gene TLR9 and COVID-19.